DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,505,810 | +3.4% | 10,100 | 0.0% | 0.37% | +8.6% |
Q2 2023 | $2,424,000 | -4.8% | 10,100 | 0.0% | 0.34% | -10.1% |
Q1 2023 | $2,545,604 | -5.0% | 10,100 | 0.0% | 0.38% | -9.8% |
Q4 2022 | $2,680,742 | +2.7% | 10,100 | 0.0% | 0.42% | -2.8% |
Q3 2022 | $2,609,000 | +1.9% | 10,100 | 0.0% | 0.43% | +23.2% |
Q2 2022 | $2,561,000 | +118.3% | 10,100 | +152.5% | 0.35% | +158.5% |
Q1 2022 | $1,173,000 | +13.8% | 4,000 | -60.0% | 0.14% | 0.0% |
Q4 2018 | $1,031,000 | -5.2% | 10,000 | 0.0% | 0.14% | -37.5% |
Q3 2018 | $1,087,000 | +10.1% | 10,000 | 0.0% | 0.22% | +11.3% |
Q2 2018 | $987,000 | +0.8% | 10,000 | 0.0% | 0.19% | +32.0% |
Q1 2018 | $979,000 | +5.5% | 10,000 | 0.0% | 0.15% | -17.9% |
Q4 2017 | $928,000 | +8.2% | 10,000 | 0.0% | 0.18% | +9.8% |
Q3 2017 | $858,000 | +12.9% | 10,000 | +11.1% | 0.16% | +7.9% |
Q2 2017 | $760,000 | -73.3% | 9,000 | -70.0% | 0.15% | -62.0% |
Q1 2016 | $2,846,000 | +16.4% | 30,000 | +5.1% | 0.40% | +60.7% |
Q2 2015 | $2,444,000 | -55.7% | 28,550 | -56.1% | 0.25% | -56.7% |
Q1 2015 | $5,519,000 | -35.6% | 65,000 | -35.0% | 0.57% | -39.6% |
Q4 2014 | $8,571,000 | +12.8% | 100,000 | 0.0% | 0.95% | -9.4% |
Q3 2014 | $7,598,000 | -3.5% | 100,000 | 0.0% | 1.04% | +12.6% |
Q2 2014 | $7,873,000 | +5.0% | 100,000 | 0.0% | 0.93% | +16.0% |
Q1 2014 | $7,500,000 | +49.5% | 100,000 | +53.8% | 0.80% | +49.6% |
Q4 2013 | $5,018,000 | -19.6% | 65,000 | -27.8% | 0.53% | -21.5% |
Q3 2013 | $6,239,000 | +9.5% | 90,000 | 0.0% | 0.68% | +21.4% |
Q2 2013 | $5,697,000 | – | 90,000 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |